Health Care Technology
Company Overview of Ocimum Biosolutions, Ltd.
Ocimum Biosolutions, Ltd. provides integrated life science informatics solutions for global outsourcing companies. The company offers laboratory information management system solutions, including Biotracker, an adaptive platform for sample management, data management, inventory management, and instrument management; and Facility Tracker, a Web based ready-to-use software for facility management requirements. It also offers biologics data management solutions, such as Sciantis to track screening, engineering, and production aspects of biological clones. In addition, the company offers database solutions, including BioExpress System, a gene expression reference database; ToxExpress program to ...
Plot No. 12/2, Sector-1
HUDA Techno Enclave
Hyderabad, 500 081
Founded in 2000
Key Executives for Ocimum Biosolutions, Ltd.
Co-founder, Chief Executive Officer and Director
Co-founder, President, Chief Financial Officer and Director
Co-founder, Chief Scientific Officer and Director
Director of Marketing Alliances and Outreach
Compensation as of Fiscal Year 2014.
Ocimum Biosolutions, Ltd. Key Developments
Ocimum Biosolutions Launches Ascenta 5.0
Apr 15 14
Ocimum Biosolutions launched Ascenta 5.0 with new sample sets pre-curated from public repositories. ASCENTA® System v5.0 is a biomarker discovery knowledge base with matched disease - normal sample sets plus analytical tools that assess, prioritize, and qualify gene targets - across tissues, across pathways or diseases conditions. ASCENTA includes gene expression data from 10,000+ clinical samples generated at Gene Logic. With this release Ocimum offers additional 2,000 Affymetrix data from Gene Expression Omnibus (GEO), a step forward to keep up with today’s high throughput science and in turn enable in-depth exploration of disease context.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries